The NasoNeb® brand was launched with a single mission: to help people feel and breathe better. Many nasal and sinus therapies stop short of delivering the results that patients and their doctors desire. And so, the NasoNeb System was introduced in 2009 by prescription only and brought over the counter in 2018.
“Sinus conditions such as nasal allergies, chronic sinusitis and nasal polyps can be debilitating, affecting the sinus sufferer and those close to them. The NasoNeb Sinus Therapy System ensures access to state-of-the art nasal drug delivery therapy to more people than ever before,” said William Flickinger, Innovator and President.
How it Works
The NasoNeb Sinus Therapy System is a medical delivery device which allows delivery of product solely to the nasal and paranasal sinus cavities. It has a unique combination of droplet size, airflow, and fluid volume depositing product where it is needed most. Other delivery devices reach a limited area of the nasal cavity, deliver a weak solution, or deliver a portion of the medication to the lungs, which can cause unwanted side effects.
Backed by Science
NasoNeb technology has been the delivery device of choice in multiple peer-reviewed trials, where it has demonstrated positive outcomes in chronic sinusitis and allergic rhinitis patients. “Reaching those people who have not responded to therapy despite their physician’s best efforts, is paramount for NasoNeb, Inc,” says Flickinger. “And we want to continue to build a brand that is both backed by science, and comfortable and easy for people to use.”
Our Sustainability Commitment
Now on its third generation of products, the NasoNeb development team focuses on improvements in weight, package volume, power consumption and manufacturing processes in order improve the environmental impact of manufacture, distribution and use. And this commitment continues forward with every next-generation system.
Company’s Keywords:
<0
<
<
Your request has been submitted successfully.
Own or work here?